#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small for dates baby Orthostatic hypotension Systemic lupus erythematosus Adrenogenital syndrome Cytokine release syndrome Neuroblastoma recurrent Desmoplastic small round cell tumour Cutaneous T-cell lymphoma Anal squamous cell carcinoma Hepatic angiosarcoma Complex regional pain syndrome Non-Hodgkin's lymphoma Neoplasm malignant Bronchiolitis Oropharyngeal squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic Fragile X syndrome – Basic Information Myxofibrosarcoma – Treatment Wolfram syndrome – Life with Disease Mantle cell lymphoma stage II – Trials in Disease Prader-Willi syndrome – Life with Disease Nephrotic syndrome – Life with Disease Hyperoxaluria – Diagnostics Antisynthetase syndrome – Diagnostics Bronchopulmonary dysplasia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dazodalibep Linperlisib Stx-241 Neridronate Sodium Opevesostat DESMOPRESSIN ACETATE Naloxone Benzathine Benzylpenicillin Trospium Chloride Decitabine Thiamazole Pd01B Estradiol Valerate Alclometasone Dipropionate Floxuridine Gskvx000000008885 TEDUGLUTIDE ENSIFENTRINE Loncastuximab Tesirine Gsk3858279 More therapies…

    Learn about Your Condition

    Coeliac disease Hepatobiliary cancer Juvenile psoriatic arthritis Macular degeneration Obesity Tertiary adrenal insufficiency Bladder cancer stage II Adenovirus infection Anal fissure Prinzmetal angina Endometriosis Post procedural oedema Pyoderma gangrenosum Vestibular disorder Antisynthetase syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on the Safety and Effectiveness of Metal Panel Allergens for Diagnosing Allergic Contact Dermatitis and Eczema in Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Eczema
    Investigated Drugs:
    • AMMONIUM TITANIUM OXALATE MONOHYDRATE
    • GOLD SODIUM THIOSULFATE
    • MANGANESE CHLORIDE TETRAHYDRATE
    Germany Italy The Netherlands

  • Study Comparing the Effectiveness and Safety of Botulinum Toxin Type A Products for Treating Frown Lines in Adults

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Botulinum Toxin Type A – Haemagglutinin Complex
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    The Netherlands

  • Study on AUP1602-C for Treating Non-Healing Diabetic Foot Ulcers in Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic foot
    Investigated Drugs:
    • Aup1602-C
    Italy

  • Study of Pembrolizumab for Patients with High-Risk Stage IIB/IIC Melanoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Pembrolizumab
    France

  • Study on Improving Burn Scars with Adipose-Derived Stem Cells and Autologous Stromal Vascular Fraction for Patients with Hypertrophic Scarring

    Not yet recruiting

    1 1
    Investigated Diseases:
    • Hypertrophic scar
    Investigated Drugs:
    • Adrc001
    Denmark

  • Study on the Effectiveness and Safety of Metformin and Methyl Aminolevulinate in Daylight Therapy for Actinic Keratosis Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Actinic keratosis
    Investigated Drugs:
    • Metformin Embonate
    • Methyl Aminolevulinate Hydrochloride
    Spain
Previous Page
1 … 26 27 28 29 30 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!